Cargando…
Interventional therapies for pulmonary embolism
Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most frequent cause of cardiovascular death. The clinical presentation of PE is variable, and choosing the appropriate treatment for individual patients can be challenging. Traditionally, treatment of PE has involved a c...
Autores principales: | Götzinger, Felix, Lauder, Lucas, Sharp, Andrew S. P., Lang, Irene M., Rosenkranz, Stephan, Konstantinides, Stavros, Edelman, Elazer R., Böhm, Michael, Jaber, Wissam, Mahfoud, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180624/ https://www.ncbi.nlm.nih.gov/pubmed/37173409 http://dx.doi.org/10.1038/s41569-023-00876-0 |
Ejemplares similares
-
Mechanical thrombectomy in intermediate- and high-risk acute pulmonary embolism: hemodynamic outcomes at three months
por: Lauder, Lucas, et al.
Publicado: (2023) -
Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis
por: Al-Terki, Hani, et al.
Publicado: (2023) -
Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study
por: Kunz, Michael, et al.
Publicado: (2023) -
Arterial hypertension – Clinical trials update 2021
por: Al Ghorani, Hussam, et al.
Publicado: (2022) -
Pacemaker‐Based Cardiac Neuromodulation Therapy for the Treatment of Hypertension: The New Kid on the Block
por: Lauder, Lucas, et al.
Publicado: (2021)